Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)

CrofelemerPositive

AI Analysis

Summary

Jaguar Health announced that an additional infant patient will receive crofelemer through a compassionate use program for treatment of intestinal failure caused by microvillus inclusion disease.

Outcome Details

Compassionate use authorization for additional infant patient

Importance:4/10

Sentiment:

0.50

compassionate userare diseasepediatricintestinal failureMVID

Related Companies

$JAGX

Read the original article

Published by yahoo_finance on July 22, 2026 1:00 PM

Read Original